Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Aug;30(6):315-325.
doi: 10.1016/j.tcm.2020.05.004. Epub 2020 May 28.

Management of Cardiovascular Disease During Coronavirus Disease (COVID-19) Pandemic

Sarju Ganatra  1 , Sourbha S Dani  2 , Sachin Shah  2 , Aarti Asnani  3 , Tomas G Neilan  4 , Daniel Lenihan  5 , Bonnie Ky  6 , Ana Barac  7 , Salim S Hayek  8 , Monika Leja  8 , Joerg Herrmann  9 , Paaladinesh Thavendiranathan  10 , Michael Fradley  11 , Vigyan Bang  2 , Katherine Shreyder  2 , Rohan Parikh  2 , Rushin Patel  2 , Amitoj Singh  2 , Simarjeet Brar  2 , Avirup Guha  12 , Dipti Gupta  13 , Paolo Mascari  2 , Richard D Patten  2 , David M Venesy  2 , Anju Nohria  14 , Frederic S Resnic  2
Affiliations
Review

Management of Cardiovascular Disease During Coronavirus Disease (COVID-19) Pandemic

Sarju Ganatra et al. Trends Cardiovasc Med. 2020 Aug.

Abstract

Patients with pre-existing cardiovascular disease and risk factors are more likely to experience adverse outcomes associated with the novel coronavirus disease-2019 (COVID-19). Additionally, consistent reports of cardiac injury and de novo cardiac complications, including possible myocarditis, arrhythmia, and heart failure in patients without prior cardiovascular disease or significant risk factors, are emerging, possibly due to an accentuated host immune response and cytokine release syndrome. As the spread of the virus increases exponentially, many patients will require medical care either for COVID-19 related or traditional cardiovascular issues. While the COVID-19 pandemic is dominating the attention of the healthcare system, there is an unmet need for a standardized approach to deal with COVID-19 associated and other traditional cardiovascular issues during this period. We provide consensus guidance for the management of various cardiovascular conditions during the ongoing COVID-19 pandemic with the goal of providing the best care to all patients and minimizing the risk of exposure to frontline healthcare workers.

Keywords: COVID-19, Cardiovascular disease; Coronavirus; SARS-CoV-2.

PubMed Disclaimer

Figures

Fig 1
Fig. 1
General approach for patient care during COVID-19 pandemic
Fig 2
Fig. 2
Approach to troponin elevation in patients with suspected or confirmed COVID-19
Fig 3
Fig. 3
Proposed management pathway for COVID-19-associated myocardial injury
Fig 4
Fig. 4
Management of acute coronary syndrome in patients with suspected or confirmed COVID-19
Fig 5
Fig. 5
Management of cardiogenic shock in patients with suspected or confirmed COVID-19. Abbreviations: BiV: biventricular, CI: cardiac index, CVP: central venous pressure, SCvO2: central venous oxygen saturation, tPA: tissue plasminogen activator.
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). 16-24 February 2020. Available at: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mis... Accessed March 9, 2020.
    1. Zheng Y-Y, Ma Y-T, Zhang J-Y, Xie X. COVID-19 and the cardiovascular system. Nature Reviews Cardiology. 2020 - PMC - PubMed
    1. Ganatra S, Hammond SP, Nohria A. The Novel Coronavirus Disease (COVID-19) Threat for Patients with Cardiovascular Disease and Cancer. JACC: CardioOncology. 2020:80. - PMC - PubMed
    1. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan. China: a retrospective cohort study. The Lancet. 2020 - PMC - PubMed
    1. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 - PMC - PubMed